Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Serum sCD14, polymorphism of CD14(-260) and periodontal infection.

Raunio T, Knuuttila M, Karttunen R, Vainio O, Tervonen T.

Oral Dis. 2009 Oct;15(7):484-9. doi: 10.1111/j.1601-0825.2009.01573.x. Epub 2009 Jun 4.

PMID:
19500269
2.

CD14 C(-260)-->T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease.

Koenig W, Khuseyinova N, Hoffmann MM, März W, Fröhlich M, Hoffmeister A, Brenner H, Rothenbacher D.

J Am Coll Cardiol. 2002 Jul 3;40(1):34-42.

3.

Soluble CD14 in periodontitis.

Nicu EA, Laine ML, Morré SA, Van der Velden U, Loos BG.

Innate Immun. 2009 Apr;15(2):121-8. doi: 10.1177/1753425908101577.

PMID:
19318422
4.

The CD14 -159C-to-T promoter polymorphism in periodontal disease.

Folwaczny M, Glas J, Török HP, Fricke K, Folwaczny C.

J Clin Periodontol. 2004 Nov;31(11):991-5.

PMID:
15491315
5.

CD14 gene promoter polymorphism in different clinical forms of tuberculosis.

Pacheco E, Fonseca C, Montes C, Zabaleta J, García LF, Arias MA.

FEMS Immunol Med Microbiol. 2004 Apr 9;40(3):207-13.

6.

Estimation of sCD14 levels in saliva obtained from patients with various periodontal conditions.

Isaza-Guzmán DM, Aristizábal-Cardona D, Martínez-Pabón MC, Velásquez-Echeverri H, Tobón-Arroyave SI.

Oral Dis. 2008 Jul;14(5):450-6.

PMID:
18938271
7.

Polymorphisms in the CD14 and IL-6 genes associated with periodontal disease.

Tervonen T, Raunio T, Knuuttila M, Karttunen R.

J Clin Periodontol. 2007 May;34(5):377-83.

PMID:
17448042
8.

CD14 C(-260)T gene polymorphism, circulating soluble CD14 levels and arteriosclerosis.

Amar J, Ruidavets JB, Bal dit Sollier C, Bongard V, Boccalon H, Chamontin B, Drouet L, Ferrières J.

J Hypertens. 2004 Aug;22(8):1523-8.

PMID:
15257175
9.

CD14 C(-159)T polymorphism is a risk factor for development of pulmonary tuberculosis.

Rosas-Taraco AG, Revol A, Salinas-Carmona MC, Rendon A, Caballero-Olin G, Arce-Mendoza AY.

J Infect Dis. 2007 Dec 1;196(11):1698-706. Epub 2007 Oct 25.

PMID:
18008256
10.

Promoter polymorphism in the CD14 gene and concentration of soluble CD14 in patients with in-stent restenosis after elective coronary stenting.

Shimada K, Miyauchi K, Mokuno H, Watanabe Y, Iwama Y, Shigekiyo M, Matsumoto M, Okazaki S, Tanimoto K, Kurata T, Sato H, Daida H.

Int J Cardiol. 2004 Mar;94(1):87-92.

PMID:
14996480
11.

Soluble CD14 receptor expression and monocyte heterogeneity but not the C-260T CD14 genotype are associated with severe acute pancreatitis.

Rahman SH, Salter G, Holmfield JH, Larvin M, McMahon MJ.

Crit Care Med. 2004 Dec;32(12):2457-63.

PMID:
15599151
12.

Association of the -159 CD14 gene polymorphism and lack of association of the -308 TNFA and Q551R IL-4RA polymorphisms with severe chronic periodontitis in Swedish Caucasians.

Donati M, Berglundh T, Hytönen AM, Hahn-Zoric M, Hanson LA, Padyukov L.

J Clin Periodontol. 2005 May;32(5):474-9.

PMID:
15842262
13.

Clinical application of human β-defensin and CD14 gene polymorphism in evaluating the status of chronic inflammation.

Loo WT, Bai LJ, Fan CB, Yue Y, Dou YD, Wang M, Liang H, Cheung MN, Chow L, Li JL, Tian Y, Qing L.

J Transl Med. 2012 Sep 19;10 Suppl 1:S9. doi: 10.1186/1479-5876-10-S1-S9. Epub 2012 Sep 19.

14.
15.

[The influence of CD14 genomic polymorphism on CD14 gene expression as well as protein release and its clinical significance in patients with extensive burns].

Lin J, Yao YM, Huang ZH, Yu Y, Zhu JM, Chai JK, Sheng ZY.

Zhonghua Wai Ke Za Zhi. 2006 Jul 1;44(13):907-10. Chinese.

PMID:
17067484
16.

The -159C/T polymorphism in the promoter region of the CD14 gene is associated with advanced liver disease and higher serum levels of acute-phase proteins in heavy drinkers.

Campos J, Gonzalez-Quintela A, Quinteiro C, Gude F, Perez LF, Torre JA, Vidal C.

Alcohol Clin Exp Res. 2005 Jul;29(7):1206-13.

PMID:
16046876
17.

CD14 polymorphisms and serum CD14 levels through childhood: a role for gene methylation?

Munthe-Kaas MC, Torjussen TM, Gervin K, Lødrup Carlsen KC, Carlsen KH, Granum B, Hjorthaug HS, Undlien D, Lyle R.

J Allergy Clin Immunol. 2010 Jun;125(6):1361-8. doi: 10.1016/j.jaci.2010.02.010. Epub 2010 Apr 15.

PMID:
20398919
18.

Influence of CD14 polymorphism on CD14 expression in patients with extensive burns.

Lin J, Yao YM, Dong N, Chai JK, Yu Y, Hou XX, Zhu JM, Sheng ZY.

Burns. 2009 May;35(3):365-71. doi: 10.1016/j.burns.2008.07.014. Epub 2008 Oct 31.

PMID:
18951711
19.

The differential effect of genetic variation on soluble CD14 levels in human plasma and milk.

Guerra S, Carla Lohman I, LeVan TD, Wright AL, Martinez FD, Halonen M.

Am J Reprod Immunol. 2004 Sep;52(3):204-11.

PMID:
15373760
20.

[Distribution and clinical significance of CD14 promoter-159C/T polymorphism in patients with extensive burn].

Dong N, Yao YM, Yu Y, Cao YJ, Sheng ZY.

Zhonghua Shao Shang Za Zhi. 2009 Apr;25(2):115-8. Chinese.

PMID:
19799036

Supplemental Content

Support Center